‘The US Is Catching Up’ – Accord’s Kokino On Biosimilar Market Dynamics
Firm’s US President Talks PBMs, The Inflation Reduction Act And Interchangeability
In the second part of his interview with Generics Bulletin, Chrys Kokino – president of Accord US – talks about how the US biosimilars market is catching up with Europe, as well as discussing aspects such as PBMs, the Inflation Reduction Act and biosimilar interchangeability.
